Holen Sie sich die Stockscreener-App
27.99
4.11%
-1.20
Schlusskurs vom Vortag:
$29.19
Offen:
$29.41
24-Stunden-Volumen:
481.52K
Relative Volume:
0.78
Marktkapitalisierung:
$1.49B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-17.39
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
-9.71%
1M Leistung:
-2.85%
6M Leistung:
+160.37%
1J Leistung:
+128.49%
1-Tages-Spanne:
$27.82
$30.26
1-Wochen-Bereich:
$24.88
$33.99
52-Wochen-Spanne:
$6.42
$33.99
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Compare TYRA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
27.99 | 1.56B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-10 | Eingeleitet | William Blair | Outperform |
| 2026-01-28 | Eingeleitet | Barclays | Overweight |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-05-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
DKAs Burden The Clinical and Economic Impact - William Blair
Is Tyra Biosciences Inc.’s ROE strong enoughJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
Tyra Biosciences Advances TYRA-300 Bladder Cancer Trial: What Investors Should Watch - TipRanks
Wedbush Increases Tyra Biosciences (NASDAQ:TYRA) Price Target to $53.00 - MarketBeat
Growth Stocks To Follow Today – February 11th - Defense World
Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month HighTime to Buy? - MarketBeat
Wedbush Raises Price Target on Tyra Bioscience to $53 From $37, Keeps Outperform Rating - marketscreener.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can Tyra Biosciences Inc. continue delivering strong returnsTrade Analysis Report & Weekly Stock Performance Updates - mfd.ru
William Blair initiates coverage on Tyra Biosciences stock with Outperform rating - Investing.com Canada
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛
William Blair Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $59.62 - 富途牛牛
Tyra Biosciences stock hits 52-week high, reaching $31.0 By Investing.com - Investing.com South Africa
Tyra Biosciences stock hits 52-week high, reaching $31.0 - Investing.com
Nasdaq Moves: Is Crown Holdings Inc a speculative investmentTrade Ideas & Low Volatility Stock Suggestions - baoquankhu1.vn
AlphaQuest LLC Has $421,000 Holdings in Tyra Biosciences, Inc. $TYRA - MarketBeat
June Brings on Some Huge Insider Buying - AOL.com
(TYRA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Tyra Biosciences Advances BEACH301 Dose Escalation - TipRanks
Tyra Biosciences (TYRA) Price Target Increased by 24.36% to 42.58 - Nasdaq
Resistance Check: Is Tyra Biosciences Inc a strong candidate for buy and holdJuly 2025 Update & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $50 - 富途牛牛
Jefferies Financial Group Forecasts Strong Price Appreciation for Tyra Biosciences (NASDAQ:TYRA) Stock - MarketBeat
Top Growth Stocks To Watch Now – January 31st - Defense World
Big Picture: What are the risks of holding Tyra Biosciences IncMarket Risk Summary & Real-Time Sentiment Analysis - baoquankhu1.vn
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 17% Upside Potential in Precision Medicine - DirectorsTalk Interviews
Forecast Cut: Can Tyra Biosciences Inc continue delivering strong returnsWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $59 - 富途牛牛
Tyra Biosciences stock price target raised to $55 from $35 at Raymond James - Investing.com Canada
Barclays Initiates Coverage of Tyra Biosciences (TYRA) with Overweight Recommendation - Nasdaq
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month HighShould You Buy? - MarketBeat
Tyra Biosciences stock hits all-time high of 31.58 USD - Investing.com
Tyra Biosciences stock hits all-time high of 31.58 USD By Investing.com - Investing.com South Africa
Technical Analysis: Can Tyra Biosciences Inc continue delivering strong returns2025 Buyback Activity & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Assessing Tyra Biosciences (TYRA) Valuation After Piper Sandler Reaffirms Overweight On Dabogratinib Prospects - Sahm
(TYRA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Promising Growth Stocks To Watch NowJanuary 25th - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Stock Rating Lowered by Wall Street Zen - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Shares Down 5.1%What's Next? - MarketBeat
Tyra Biosciences (TYRA) Stock Report: Biotechnology Innovator with an 8.61% Upside Potential - DirectorsTalk Interviews
Piper Sandler Issues Positive Forecast for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat
Piper Sandler raises Tyra Biosciences stock price target to $42 on growth outlook - Investing.com Canada
Tyra Biosciences stock hits 52-week high at 30.85 USD By Investing.com - Investing.com Australia
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighHere's Why - MarketBeat
Tyra Biosciences stock hits 52-week high at 30.85 USD - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tyra Biosciences, Inc. (TYRA): Investor Outlook on a Promising Biotech with 15.68% Upside Potential - DirectorsTalk Interviews
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial - openPR.com
Tyra Biosciences (TYRA) Is Up 9.4% After New COO Hire And 52-Week High Has The Bull Case Changed? - Sahm
Can Tyra Biosciences Inc. stock surprise with earnings upsideJuly 2025 Drop Watch & Technical Entry and Exit Alerts - ulpravda.ru
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):